PIGNOCHINO, Ymera
PIGNOCHINO, Ymera
SCIENZE CLINICHE E BIOLOGICHE
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.
2012-01-01 Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M.
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways
2012-01-01 Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G.
Adoptive immunotherapy against sarcomas.
2015-01-01 Mesiano G; Leuci V; Giraudo L; Gammaitoni L; Carnevale Schianca F; Cangemi M; Rotolo R; Capellero S; Pignochino Y; Grignani G; Aglietta M; Sangiolo D.
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells
2018-01-01 Leuci, V.; Casucci, G.M.; Grignani, G.; Rotolo, R.; Rossotti, U.; Vigna, E.; Gammaitoni, L.; Mesiano, G.; Fiorino, E.; Donini, C.; Pisacane, A.; ambrosio, L.D.; Pignochino, Y.; Aglietta, M.; Bondanza, A.; Sangiolo, D.
Crosstalk between macrophages and myxoid liposarcoma cells increases spreading and invasiveness of tumor cells
2021-01-01 Minopoli M.; Sarno S.; Cannella L.; Tafuto S.; Scognamiglio G.; Gallo M.; Fazioli F.; Azzaro R.; Apice G.; De Angelis B.; Tamborini E.; Garofalo C.; Pignochino Y.; Mercatali L.; Ibrahim T.; Falcioni R.; Valenti B.; Maestro R.; Scotlandi K.; De Chiara A.; Carriero M.V.
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes
2020-01-01 Leuci, Valeria; Donini, Chiara; Grignani, Giovanni; Rotolo, Ramona; Mesiano, Giulia; Fiorino, Erika; Gammaitoni, Loretta; D'Ambrosio, Lorenzo; Merlini, Alessandra; Landoni, Elisa; Medico, Enzo; Capellero, Sonia; Giraudo, Lidia; Cattaneo, Giulia; Iaia, Ilenia; Pignochino, Ymera; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Fagioli, Franca; Ferrone, Soldano; Aglietta, Massimo; Gianpietro, Dotti; Sangiolo, Dario
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy
2018-01-01 Mesiano, Giulia; Grignani, Giovanni; Fiorino, Erika; Leuci, Valeria; Rotolo, Ramona; D'Ambrosio, Lorenzo; Salfi, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Pisacane, Alberto; Butera, Sara; Pignochino, Ymera; Basiricó, Marco; Capozzi, Federica; Sapino, Anna; Aglietta, Massimo; Sangiolo, Dario
Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells
2017-01-01 Gammaitoni L; Giraudo L ; Macagno M; Leuci V; Mesiano G; Rotolo R; Sassi F; Sanlorenzo M; Zaccagna A; Pisacane A; Senetta R; Cangemi M; Cattaneo G; Martin V; Coha V; Gallo S; Pignochino Y; Sapino A; Grignani G; Carnevale-Schianca F; Aglietta M; Sangiolo D
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
2014-01-01 Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G.
Delving into PARP inhibition from bench to bedside and back
2020-01-01 Grignani G.; Merlini A.; Sangiolo D.; D'Ambrosio L.; Pignochino Y.
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination
2022-01-01 Alessandra Merlini, Maria Laura Centomo, Giulio Ferrero, Giulia Chiabotto, Umberto Miglio,Enrico Berrino, Giorgia Giordano, Silvia Brusco, Alberto Pisacane, Elena Maldi, Ivana Sarotto,Federica Capozzi, Cristina Lano, Claudio Isella, Giovanni Crisafulli, Massimo Aglietta,Angelo Paolo Dei Tos, Marta Sbaraglia,Dario Sangiolo, Lorenzo D’Ambrosio, Alberto Bardelli, Ymera Pignochino, Giovanni Grignani
Effective Activity of Cytokine Induced Killer Cells against Autologous Metastatic Melanoma including Cells with Stemness Features.
2013-01-01 Gammaitoni L;Giraudo L;Leuci V;Todorovic M;Mesiano G;Picciotto F;Pisacane A;Zaccagna A;Volpe MG;Gallo S;Caravelli D;Giacone E;Venesio T;Balsamo A;Pignochino Y;Grignani G;Carnevale-Schianca F;Aglietta M;Sangiolo D
Enhancing proteotoxic stress in leiomyosarcoma cells triggers mitochondrial dysfunctions, cell death, and antitumor activity in vivo
2021-01-01 Iuliano L.; Drioli S.; Pignochino Y.; Cafiero C.M.; Minisini M.; D'Este F.; Picco R.; Dalla E.; Giordano G.; Grignani G.; Di Giorgio E.; Benedetti F.; Felluga F.; Brancolini C.
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma
2021-01-01 Giordano G.; Merlini A.; Ferrero G.; Mesiano G.; Fiorino E.; Brusco S.; Centomo M.L.; Leuci V.; D'ambrosio L.; Aglietta M.; Sangiolo D.; Grignani G.; Pignochino Y.
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.
2011-01-01 Peraldo-Neia C; Migliardi G; Mello-Grand M; Montemurro F; Segir R; Pignochino Y; Cavalloni G; Torchio B; Mosso L; Chiorino G; Aglietta M.
Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers.
2012-01-01 Todorovic M; Mesiano G; Gammaitoni L; Leuci V; Giraudo Diego L; Cammarata C; Jordaney N; Carnevale-Schianca F; Gallo S; Fagioli F; Piacibello W; Elia AR; Pignochino Y; Dell'aglio C; Grignani G; Cignetti A; Aglietta M; Sangiolo D.
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation
2019-01-01 De Feo A.; Sciandra M.; Ferracin M.; Felicetti F.; Astolfi A.; Pignochino Y.; Picci P.; Care A.; Scotlandi K.
Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study
2005-01-01 BERGER M; FRAIRIA R; PIACIBELLO W; SANAVIO F; PALMERO A; VENTURI C; PIGNOCHINO Y; BERTA L; MADON E; AGLIETTA M; FAGIOLI F
Generation and characterization of two primary cultures of osteosarcoma and Ewing’s sarcoma
2013-01-01 Signorino Elena, Sanavio Fiorella, Pittana Laura, Muraro Michela, Castiglia Sara, Ferrero Ivana, Pignochino Ymera, Basificò M, Aglietta Massimo, Fagioli Franca
Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab
2008-01-01 Cavalloni G; Sarotto I; Pignochino Y; Gammaitoni L; Migliardi G; Sgro L; Piacibello W; Risio M; Aglietta M; Leone F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. | 2012 | Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M. | |
| Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways | 2012 | Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G. | |
| Adoptive immunotherapy against sarcomas. | 2015 | Mesiano G; Leuci V; Giraudo L; Gammaitoni L; Carnevale Schianca F; Cangemi M; Rotolo R; Capellero S; Pignochino Y; Grignani G; Aglietta M; Sangiolo D. | |
| CD44v6 as innovative sarcoma target for CAR-redirected CIK cells | 2018 | Leuci, V.; Casucci, G.M.; Grignani, G.; Rotolo, R.; Rossotti, U.; Vigna, E.; Gammaitoni, L.; Mesiano, G.; Fiorino, E.; Donini, C.; Pisacane, A.; ambrosio, L.D.; Pignochino, Y.; Aglietta, M.; Bondanza, A.; Sangiolo, D. | |
| Crosstalk between macrophages and myxoid liposarcoma cells increases spreading and invasiveness of tumor cells | 2021 | Minopoli M.; Sarno S.; Cannella L.; Tafuto S.; Scognamiglio G.; Gallo M.; Fazioli F.; Azzaro R.; Apice G.; De Angelis B.; Tamborini E.; Garofalo C.; Pignochino Y.; Mercatali L.; Ibrahim T.; Falcioni R.; Valenti B.; Maestro R.; Scotlandi K.; De Chiara A.; Carriero M.V. | |
| CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes | 2020 | Leuci, Valeria; Donini, Chiara; Grignani, Giovanni; Rotolo, Ramona; Mesiano, Giulia; Fiorino, Erika; Gammaitoni, Loretta; D'Ambrosio, Lorenzo; Merlini, Alessandra; Landoni, Elisa; Medico, Enzo; Capellero, Sonia; Giraudo, Lidia; Cattaneo, Giulia; Iaia, Ilenia; Pignochino, Ymera; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Fagioli, Franca; Ferrone, Soldano; Aglietta, Massimo; Gianpietro, Dotti; Sangiolo, Dario | |
| Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy | 2018 | Mesiano, Giulia; Grignani, Giovanni; Fiorino, Erika; Leuci, Valeria; Rotolo, Ramona; D'Ambrosio, Lorenzo; Salfi, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Pisacane, Alberto; Butera, Sara; Pignochino, Ymera; Basiricó, Marco; Capozzi, Federica; Sapino, Anna; Aglietta, Massimo; Sangiolo, Dario | |
| Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells | 2017 | Gammaitoni L; Giraudo L ; Macagno M; Leuci V; Mesiano G; Rotolo R; Sassi F; Sanlorenzo M; Zaccagna A; Pisacane A; Senetta R; Cangemi M; Cattaneo G; Martin V; Coha V; Gallo S; Pignochino Y; Sapino A; Grignani G; Carnevale-Schianca F; Aglietta M; Sangiolo D | |
| Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas. | 2014 | Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G. | |
| Delving into PARP inhibition from bench to bedside and back | 2020 | Grignani G.; Merlini A.; Sangiolo D.; D'Ambrosio L.; Pignochino Y. | |
| DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination | 2022 | Alessandra Merlini, Maria Laura Centomo, Giulio Ferrero, Giulia Chiabotto, Umberto Miglio,Enrico Berrino, Giorgia Giordano, Silvia Brusco, Alberto Pisacane, Elena Maldi, Ivana Sarotto,Federica Capozzi, Cristina Lano, Claudio Isella, Giovanni Crisafulli, Massimo Aglietta,Angelo Paolo Dei Tos, Marta Sbaraglia,Dario Sangiolo, Lorenzo D’Ambrosio, Alberto Bardelli, Ymera Pignochino, Giovanni Grignani | |
| Effective Activity of Cytokine Induced Killer Cells against Autologous Metastatic Melanoma including Cells with Stemness Features. | 2013 | Gammaitoni L;Giraudo L;Leuci V;Todorovic M;Mesiano G;Picciotto F;Pisacane A;Zaccagna A;Volpe MG;Gallo S;Caravelli D;Giacone E;Venesio T;Balsamo A;Pignochino Y;Grignani G;Carnevale-Schianca F;Aglietta M;Sangiolo D | |
| Enhancing proteotoxic stress in leiomyosarcoma cells triggers mitochondrial dysfunctions, cell death, and antitumor activity in vivo | 2021 | Iuliano L.; Drioli S.; Pignochino Y.; Cafiero C.M.; Minisini M.; D'Este F.; Picco R.; Dalla E.; Giordano G.; Grignani G.; Di Giorgio E.; Benedetti F.; Felluga F.; Brancolini C. | |
| Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma | 2021 | Giordano G.; Merlini A.; Ferrero G.; Mesiano G.; Fiorino E.; Brusco S.; Centomo M.L.; Leuci V.; D'ambrosio L.; Aglietta M.; Sangiolo D.; Grignani G.; Pignochino Y. | |
| Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer. | 2011 | Peraldo-Neia C; Migliardi G; Mello-Grand M; Montemurro F; Segir R; Pignochino Y; Cavalloni G; Torchio B; Mosso L; Chiorino G; Aglietta M. | |
| Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers. | 2012 | Todorovic M; Mesiano G; Gammaitoni L; Leuci V; Giraudo Diego L; Cammarata C; Jordaney N; Carnevale-Schianca F; Gallo S; Fagioli F; Piacibello W; Elia AR; Pignochino Y; Dell'aglio C; Grignani G; Cignetti A; Aglietta M; Sangiolo D. | |
| Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation | 2019 | De Feo A.; Sciandra M.; Ferracin M.; Felicetti F.; Astolfi A.; Pignochino Y.; Picci P.; Care A.; Scotlandi K. | |
| Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study | 2005 | BERGER M; FRAIRIA R; PIACIBELLO W; SANAVIO F; PALMERO A; VENTURI C; PIGNOCHINO Y; BERTA L; MADON E; AGLIETTA M; FAGIOLI F | |
| Generation and characterization of two primary cultures of osteosarcoma and Ewing’s sarcoma | 2013 | Signorino Elena, Sanavio Fiorella, Pittana Laura, Muraro Michela, Castiglia Sara, Ferrero Ivana, Pignochino Ymera, Basificò M, Aglietta Massimo, Fagioli Franca | |
| Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab | 2008 | Cavalloni G; Sarotto I; Pignochino Y; Gammaitoni L; Migliardi G; Sgro L; Piacibello W; Risio M; Aglietta M; Leone F |